Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SmithKline OTC sales jump 68% in second quarter with Panadol contribution.

This article was originally published in The Tan Sheet

Executive Summary

SMITHKLINE BEECHAM OTC SALES JUMP 68% IN SECOND QUARTER boosted by the contribution of Sterling Winthrop's international OTC business led by Panadol. SmithKline Beecham's OTC sales for the quarter were [pound]254 mil., or $403.8 mil., based on the currency translation of [pound]=$1.59. The company noted in a July 25 release that the inclusion of the Sterling products led to a 41% sales gain in Europe and 118% sales growth in international markets
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084127

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel